← back to search

Mahmoud Zureik

Tel Aviv University · FR
Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Cardiovascular Health and Disease Prevention, Lung Cancer Treatments and Mutations, and Asthma and respiratory diseases.
h-index
58
citations
14,705
works
361
NIH funding
primary concept
Medicine
email

Recent publications

Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in France.
2026cited by 1position: contributordoi
Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns.
2026cited by 0position: contributordoi
Real-world use and survival outcomes of sacituzumab govitecan in metastatic triple-negative breast cancer and hormone receptor-positive/HER2-negative metastatic breast cancer.
2026cited by 0position: contributordoi
Ambulatory artificial nutrition support use in adolescents and adults: A nationwide population-based descriptive cohort study.
2026cited by 0position: contributordoi
Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France.
2026cited by 0position: contributordoi
Development and validation of a predictive model for the risk of serious infection in patients with rheumatoid arthritis initiating a biologic or targeted synthetic DMARD: a nationwide cohort study.
2026cited by 0position: contributordoi
Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent dMMR Endometrial Cancer: A Nationwide Cohort Study in France.
2026cited by 0position: contributordoi
Nirsevimab Effectiveness at Preventing RSV-Related Hospitalization in Infants.
2025cited by 21position: contributordoi
Sociodemographic Characteristics of Infants Receiving Nirsevimab.
2025cited by 4position: contributordoi
Vasectomy Procedures on the Rise in France From 2010 to 2022.
2025cited by 3position: contributordoi
First-trimester exposure to macrolides and risk of major congenital malformations compared with amoxicillin: A French nationwide cohort study.
2025cited by 3position: contributordoi
Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study.
2025cited by 3position: contributordoi
Prolonged use of chlormadinone acetate and risk of intracranial meningioma: A population-based cohort study.
2025cited by 3position: contributordoi
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France.
2025cited by 2position: contributordoi
Long-term health outcomes following hospitalisation for COVID-19: a 30- month cohort analysis.
2025cited by 2position: contributordoi
First-Trimester mRNA COVID-19 Vaccination and Risk of Major Congenital Anomalies.
2025cited by 2position: contributordoi
Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study.
2025cited by 2position: contributordoi
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study.
2025cited by 2position: contributordoi
High-Dose Cyproterone Acetate and Intracranial Meningioma: Impact of the Risk Minimisation Measures Implemented in France in 2018-2019.
2025cited by 1position: contributordoi
Social and Regional Inequalities in Maternal Respiratory Syncytial Virus Vaccination in France.
2025cited by 0position: contributordoi
PD-L1 inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: a French nationwide cohort study.
2025cited by 0position: contributordoi
Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies.
2025cited by 0position: contributordoi
Long-Term Prognosis of Patients With Myocarditis-Reply.
2025cited by 0position: contributordoi
Intrauterine Devices and Risk of Ectopic Pregnancy.
2025cited by 0position: contributordoi
Relative Age in School and Initiation of Speech Therapy in Children.
2025cited by 0position: contributordoi
Use of oral fluoroquinolones in France between 2014 and 2023: a nationwide drug utilization study.
2025cited by 0position: contributordoi
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.
2025cited by 0position: contributordoi
Contraceptive use in France in 2012 and 2022: a descriptive analysis of two repeated nationwide cross-sectional studies.
2025cited by 0position: contributordoi
Medication Use in People Aged 90 Years and Older: A Nationwide Study.
2025cited by 0position: contributordoi
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
2024cited by 32position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Alain Weill · French Clinical Research Infrastructure Network60 papers (2019–2025)Rosemary Dray‐Spira · Conservatoire National des Arts et Métiers44 papers (2019–2025) · 25 papers (2021–2026) · 23 papers (2019–2025)Jérémie Botton · Agence Nationale de Sécurité du Médicament et des Produits de Santé18 papers (2021–2024) · 18 papers (2019–2025)Emilie Sbidian · Inserm11 papers (2021–2026) · 10 papers (2021–2024)Léa Hoisnard · Inserm7 papers (2022–2025) · 7 papers (2019–2025)Lise Duranteau · Université Paris-Saclay6 papers (2022–2025)Noémie Roland · Centre de recherche en Epidémiologie et Santé des Populations6 papers (2023–2025)Joel Coste · Public Health Agency5 papers (2019–2025)Sébastien Froelich · Wolters Kluwer Health5 papers (2022–2025) · 5 papers (2022–2024)Laura Semenzato · Caisse nationale de l'assurance maladie5 papers (2022–2022) · 4 papers (2022–2025) · 4 papers (2022–2025)Anke Neumann · Universität Hamburg4 papers (2021–2025) · 4 papers (2021–2022)